TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Colorectal Cancer Market – By Modality
1.3.2 North America Colorectal Cancer Market – By End User
1.3.3 North America Colorectal Cancer Market – By Country
2. North America Colorectal Cancer Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Colorectal Cancer– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Colorectal Cancer Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Inclination Toward Personalized Medicine
5.4 Impact Analysis
6. North America Colorectal Cancer Market– North America Analysis
6.1 North America Colorectal Cancer Market Revenue Forecast and Analysis
6.1.1 Overview
7. North America Colorectal Cancer Market Analysis – By Modality
7.1 Overview
7.2 North America Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 North America Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.2 Overview
7.4.3.3.3 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.2 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.2 Overview
7.4.4.3.3 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.2 Overview
7.4.4.4.3 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.2 Overview
7.4.4.5.3 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.2 Overview
7.4.4.6.3 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 North America Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Colorectal Cancer Market Revenue and Forecast To 2028 – By End User
8.1 Overview
8.2 North America Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis
9.1 North America: Colorectal Cancer Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.2.1 US: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.2 US: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.3 US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.1.3.1 US: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.2.1.3.2 US: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.1.2.1.3.2.1 US: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.2.1.3.2.2 US: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.2.1.3.3 US: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.2.1.4 US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.2.2 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.2 Canada: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.3 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.2.3.1 Canada: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.2.2.3.1.1 Canada: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.2.2.3.1.2 Canada: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.2.2.3.2 Canada: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.2.2.4 Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.2.3 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.2 Mexico: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.3 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.3.3.1 Mexico: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.2.3.3.2 Mexico: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.2.3.3.2.1 Mexico: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.2.3.3.2.2 Mexico: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.2.3.3.3 Mexico: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.2.3.4 Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
10. Colorectal Cancer Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11. Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Clinical Genomics Technologies Pty. Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Volitionrx Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES.
Table 1. US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 2. US: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 6. US: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 8. Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 9. Canada: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 13. Canada: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 15. Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 16. Mexico: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 20. Mexico: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
Table 22. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 23. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 24. Glossary of Terms, North America Colorectal Cancer Market